https://www.selleckchem.com/pr....oducts/dibutyryl-cam
Although patients with cancer are at an increased risk of infection-related complications, few studies have characterized their vulnerability to measles and mumps. Given the recent outbreaks and increased community vaccine hesitancy, understanding measles and mumps immunity within this population is vital. To identify a point prevalence estimate of protective measles and mumps antibodies among ambulatory patients with cancer. In this cross-sectional study, residual clinical plasma samples were obtained from consecutiv
Like
Comment
Share
